In short: Cited as evidence, not a stance — the India leg of the Fairfax case. "They own 42.9% of the publicly traded Fairfax India… Their biggest stake is the Bangalore Airport. Fairfax also receives management and performance fees from Fairfax India." This is the same fee-collector logic as the 27 August study: own the parent that collects the fees rather than the vehicle that pays them.
In short: "A very attractive investment opportunity" — and an explicit pass, on fees rather than on merit. A $4bn holding company, 84% in infrastructure and financial services, BVPS compounding $9.35 (2015) → $22.94 (2025), a 10.3% CAGR that is said to understate the truth; debt/equity below 20%. Valuation: shares at ~$18 against a $22.94 book, ~0.9x P/B, falling to ~0.7x if BIAL marks at $4bn — management's own phrase, "a discount on a discount." Capital allocation in the Singleton mould: shares issued at the 2018 peak, then 23.2m shares bought back for $303.9m at an average $13.09 — 14.8% of shares issued since inception. Chairman Benjamin Watsa, Prem's son and designated successor. The verdict: "If Fairfax India didn't have to pay fees to Fairfax, we would probably buy them for the Tiny Titans Portfolio" — i.e. owned indirectly, not directly.
Fairfax India is a listed pot of Indian assets, run from Canada by Prem Watsa's son Benjamin. It owns about $4bn of things, mostly infrastructure and financial businesses, and more than half of that is one asset: Bangalore airport.
The interesting part is an accounting quirk. When a holding company owns shares in a listed business, the value on its balance sheet moves with the share price every day. When it owns a private business, there is no share price, so management estimates the value themselves. Fairfax India's estimates have been deliberately cautious, and there is a clean way to prove it: the returns it has actually banked by selling things are 19% a year, and the returns it reports on the private things it still holds are 8% a year — the same team, the same period. When something is finally sold, the real value shows up all at once. Two thirds of the portfolio is valued this cautious way.
So there are two discounts stacked on each other, which is management's own phrase. The assets are carried below what they are worth, and the shares then trade below even that: book value is $22.94 a share and the shares are around $18. Management has been buying those shares back — 23.2m of them at an average $13.09, nearly 15% of everything ever issued — which is exactly what you want a manager to do when their own stock is cheap.
The event that would close the gap is an initial public offering of Anchorage, the subsidiary that holds most of the airport stake. Listing it puts a market price on the biggest asset and, on management's own figures, would take the share of the portfolio valued at real market prices from 31% to 85%. If the airport is then worth $4bn rather than the $2.9bn carried, the shares are trading at roughly 0.7x book instead of 0.9x. There is no date, and regulatory approval is still pending.
Compounding Quality nevertheless does not buy it, and says why: Fairfax India pays management and performance fees of roughly 1.8% a year — $572m over eleven years — to Fairfax, the parent, which they already own. Owning the parent gives the same India exposure and collects the fee rather than paying it.
Nothing matches this filter.
Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.